The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas – PubMed Black Hawk Supplements

BLACK HAWK: High quality ashwagandha supplement for immune system

Published article

The accurate diagnosis of brain tumour is very important in modern neuro-oncology medicine. Magnetic resonance spectroscopy (MRS) is supposed to be a promising tool for detecting cancerous lesions. However, the interpretation of MRS data is complicated by the fact that not all cancerous lesions exhibit elevated choline (Cho) levels. The main goal of our study was to investigate the lack of Cho lesion /Cho ref elevation in the population of grade II-III gliomas. 89 cases of gliomas grade II and…
Black Hawk Supplements, best supplements in the UK

The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas - PubMed

The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas

Barbara Bobek-Billewicz et al. Folia Neuropathol. 2024.

Abstract

The accurate diagnosis of brain tumour is very important in modern neuro-oncology medicine. Magnetic resonance spectroscopy (MRS) is supposed to be a promising tool for detecting cancerous lesions. However, the interpretation of MRS data is complicated by the fact that not all cancerous lesions exhibit elevated choline (Cho) levels. The main goal of our study was to investigate the lack of Cho lesion /Cho ref elevation in the population of grade II-III gliomas. 89 cases of gliomas grade II and III were used for the retrospective analysis – glioma (astrocytoma or oligodendroglioma) grade II (74 out of 89 cases [83%]) and III (15 out of 89 cases [17%]) underwent conventional MRI extended by MRS before treatment. Histopathological diagnosis was obtained either by biopsy or surgical resection. Gliomas were classified to the group of no-choline elevation when the ratio of choline measured within the tumour (Cho lesion ) to choline from NABT (Cho ref ) were equal to or lower than 1. Significant differences were observed between ratios of Cho lesion /Cr lesion calculated for no-choline elevation and glial tumour groups as well as in the NAA lesion /Cr lesion ratio between the no-choline elevation group and glial tumour group. With consistent data concerning choline level elevation and slightly lower NAA value, the Cho lesion /NAA lesion ratio is significantly higher in the WHO II glial tumour group compared to the no-choline elevation cases ( p < 0.000). In the current study the results demonstrated possibility of lack of choline elevation in patients with grade II-III gliomas, so it is important to remember that the lack of elevated choline levels does not exclude neoplastic lesion.

Keywords: MRI; brain tumour; choline; glioma grade; MRS.

PubMed Disclaimer

MeSH terms

Substances

BLACK HAWK: Best shilajit supplement for mums

Read the original publication:

The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas – PubMed